Reaction
Glycosylated Haemoglobin Abnormal reporting signals
As of the last recalculation, Glycosylated Haemoglobin Abnormal appears in 1,168 FAERS reports alongside 22 co-occurring drug terms. The strongest observed disproportionality signal is EMPAGLIFLOZIN (PRR 42.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Empagliflozin | 141 | 42.3 | 42.4 |
| Dulaglutide | 160 | 37.1 | 37.2 |
| Sitagliptin And Metformin Hydrochloride | 26 | 21.9 | 22.0 |
| Oral Semaglutide | 81 | 21.0 | 21.1 |
| Sitagliptin | 76 | 20.0 | 20.0 |
| Insulin Glargine-Yfgn | 19 | 15.7 | 15.7 |
| Human Insulin | 10 | 14.4 | 14.4 |
| Insulin Glargine | 169 | 14.1 | 14.1 |
| Glipizide | 46 | 14.0 | 14.0 |
| Metformin Er 500 Mg | 196 | 13.7 | 13.8 |
| Metformin Er 750 Mg | 196 | 13.7 | 13.8 |
| Linagliptin | 13 | 12.8 | 12.8 |
| Metformin | 210 | 12.6 | 12.6 |
| Insulin Lispro | 76 | 10.4 | 10.4 |
| Glimepiride | 20 | 9.3 | 9.3 |
| Insulin Degludec | 11 | 8.4 | 8.4 |
| Dapagliflozin | 14 | 8.0 | 8.0 |
| Canagliflozin | 13 | 7.8 | 7.8 |
| Relugolix | 10 | 7.6 | 7.6 |
| Tirzepatide | 65 | 7.5 | 7.5 |
| Alpelisib | 3 | 6.1 | 6.1 |
| Exenatide | 13 | 4.4 | 4.4 |